21 Nov 2018

BOSTON SCIENTIFIC ACQUIRING BTG

    Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders

0
12 Nov 2018

26,000-PERSON STUDY: FISH OIL AND VITAMIN D PILLS NO GUARD AGAINST CANCER OR SERIOUS HEART TROUBLE

By Liz Szabo Kaiser Health News A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems in healthy older people, according to research presented Nov. 10 at the American Heart Association Scientific Sessions. Researchers defined serious heart problems as the

0
12 Nov 2018

HHS RELEASES PHYSICAL ACTIVITY GUIDELINES FOR AMERICANS, 2ND EDITION

The U.S. Department of Health and Human Services’ second edition of the Physical Activity Guidelines for Americans was released at the American Heart Association’s Scientific Sessions meeting Nov. 11. The second edition provides evidence-based recommendations for youth ages 3 through 17 and adults to safely get the physical activity they

0
08 Nov 2018

U.S. HEALTHCARE AGENDA: ALL TALK, NO ACTION

By Drew Altman With a Democratic House, a Republican Senate and President Trump in the White House, get ready for two years of maneuvering but little progress on healthcare — unless you look beyond Washington.             What to watch: No new health legislation of any significance will pass in this Congress.

0
06 Nov 2018

CMS RELEASES FINAL 2019 PHYSICIAN FEE SCHEDULE NOV. 1

The Centers for Medicare & Medicaid Services (CMS) released the final 2019 Physician Fee Schedule (PFS) and the Quality Payment Program (QPP) rule Nov. 1. According to CMS officials, the final rule modernizes Medicare payment policies to promote access to virtual care, saving Medicare beneficiaries time and money while improving

0
02 Nov 2018

CMS DELAYS PROPOSED CHANGES TO E/M CODES IN FINAL RULE UNTIL 2021

The Centers for Medicare and Medicaid Services has proven that “final rules” are not always final. In response to complaints from physicians, CMS has delayed major changes to E/M codes until 2021. While CMS moved ahead with parts of its plan to consolidate codes for Medicare patient visits, it made

0
01 Nov 2018

WISCONSIN MEDICAID WORK PROGRAM GETS CMS OK OCT. 31

The Centers for Medicare & Medicaid Services (CMS)  approved a waiver to implement work requirements in Wisconsin’s Medicaid program Oct. 31, making it the fourth state to enact such an approach.   Under the waiver, beneficiaries in the state’s BadgerCare program would have to engage in 80 hours a month of “community

0
01 Nov 2018

HHS ANSWERS YOUR QUESTIONS ABOUT THE IPI DRUG PRICING MODEL

    By: Dan Best SEE RELATED ARTICLE: http://www.veintherapynews.com/wp-admin/post.php?post=1557&action=edit   Last week, as part of fulfilling President Trump’s promise to lower drug prices and cut down on foreign governments’ freeriding, HHS put forth a new way of paying for physician-administered drugs within Medicare, the International Price Index (IPI) Model. The model aims to:

0
31 Oct 2018

CMS SEEKS COMMENT ON PROPOSED RULE TO USE IPI PAY MODEL BY DEC 31

The Centers for Medicare & Medicaid Services intends to test whether phasing down the Medicare payment amount for selected Part B drugs to more closely align with international prices will meet President Trump’s blueprint to lower drug costs and reduce out-of-pocket costs for patients. CMS is soliciting public comments by

0
18 Oct 2018

24 MEDICARE ADVANTAGE PLANS AND 27 MEDICARE PART D DRUG PLANS AVAILABLE DURING 2019 OPEN ENROLLMENT PERIOD

With Medicare Advantage playing an increasingly larger role in Medicare, the average person on Medicare will be able to choose among 24 plans during the annual Medicare open enrollment period that began Oct. 15, according to a new analysis from KFF (the Kaiser Family Foundation). The new analysis, Medicare Advantage

0